Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond

Daniel P. Boyle*, Teresa R. Zembower

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

30 Scopus citations

Abstract

Worldwide prevalence of antimicrobial resistance is rapidly increasing, primarily a result of antibiotic misuse in the medical community. Resistant infections involving the urinary tract are typically caused by gram-negative bacteria. When treating these infections, clinicians have few effective antimicrobials to choose from and many are associated with significant adverse effects. There are now situations when clinicians are tasked with managing infections from pan-resistant organisms; thus, it is of paramount importance that spread of resistance be controlled. This review discusses common gram-negative resistance classes, highlighting the mechanisms of resistance, risk factors, type of infections, treatment, and outcomes associated with each class.

Original languageEnglish (US)
Pages (from-to)493-505
Number of pages13
JournalUrologic Clinics of North America
Volume42
Issue number4
DOIs
StatePublished - Nov 2015

Keywords

  • Antibiotic resistance
  • Carbapenem-resistant Acinetobacter baumannii
  • Carbapenem-resistant enterobacteriaceae
  • Extended-spectrum β-lactamases
  • Multidrug-resistant Pseudomonas aeruginosa
  • New Delhi metallo-β-lactamase

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond'. Together they form a unique fingerprint.

Cite this